[18F]FDOPA PET/CT 在术后高残留降钙素甲状腺髓样癌患者管理中的前瞻性研究
这项前瞻性多中心研究纳入24例术后降钙素中位824 pg/mL的甲状腺髓样癌患者,评估[18F]FDOPA PET/CT相对于常规影像的获益。结果显示[18F]FDOPA检测转移性淋巴结是常规影像的1.5倍,58.3%患者管理发生改变,但阅片一致性存在挑战。
要点
- [18F]FDOPA检测转移性淋巴结为常规影像的1.5倍(95%CI 1.25-1.84)。
- 根据肿瘤委员会,58.3%患者(95%CI 36.6-77.9)因[18F]FDOPA结果改变管理。
- [18F]FDOPA阅片不一致率20.8%(95%CI 7.1-42.2,5/24例),需学习曲线。
核心结论
- [18F]FDOPA在多中心前瞻性研究中比常规影像更有效检测转移性淋巴结,并可能改变58%病例的管理。
- [18F]FDOPA阅片仍具挑战性,在甲状腺髓样癌中需要学习曲线。
研究设计与样本
- 前瞻性、多中心研究评估[18F]FDOPA PET/CT与常规影像相比的获益。
- 研究纳入24例术后降钙素中位824 pg/mL(范围176-16418)的甲状腺髓样癌患者。
- 主要终点为按淋巴结分析转移性颈部淋巴结的相对真阳性率,次要终点包括不一致率、管理改变和阅片一致性。
主要发现
- [18F]FDOPA检测转移性淋巴结是常规影像的1.5倍(95%CI 1.25-1.84)。
- 转移灶的不一致率为46.4%(95%CI 27.5-66.1)。
- 根据肿瘤委员会,14例患者(58.3%,95%CI 36.6-77.9)在[18F]FDOPA结果后管理改变(监测或手术或修改手术或细针穿刺或局部/全身治疗)。
- [18F]FDOPA阅片不一致率为20.8%(95%CI 7.1-42.2,5/24例患者)。
临床怎么用
- 对于术后降钙素超过150 pg/ml的甲状腺髓样癌患者,国际建议在常规影像基础上加做[18F]FDOPA PET/CT。
- [18F]FDOPA结果可影响肿瘤委员会的管理决策,包括监测、手术、细针穿刺或局部/全身治疗。
- [18F]FDOPA阅片需注意学习曲线, investigator中心与集中审阅间存在不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: After surgery, beyond 150 pg/ml of calcitonin (ctn) in medullary thyroid cancer (MTC) patients, international recommendations suggest adding 6-[¹⁸F]fluoro-L-3,4-dihydroxyphenylalanine positron emission tomography ([18F]FDOPA PET/CT) to conventional imaging (CI). The aim of this study was to measure the impact of the [18F]FDOPA in the management of MTC patients. METHODS: This prospective, multicenter, study evaluated the benefit of [18F]FDOPA compared to CI. The primary endpoint was the relative true-positive rate of metastatic cervical lymph nodes in a per lymph node analysis. Secondary endpoints are discordance rate between [18F]FDOPA and CI, changes in patient management according to a board of experts and concordance between [18F]FDOPA reading in the investigating center and a centralized review. RESULTS: The study included 24 patients. The median ctn rate was 824 pg/mL (range 176-16418). Sixty lymph nodes were detected by [18F]FDOPA or CI, fifty-three were defined involved and 7 non-involved. [18F]FDOPA detected 1.5 (95% CI 1.25-1.84) times more metastatic lymph nodes compared to CI. For metastases, the discordance rate was 46.4% (95% CI 27.5-66.1). According to the tumor board, 14 patients (58.3%, 95%CI: 36.6-77.9) had a change in management after [18F]FDOPA results (monitoring or surgery or modified surgery or fine needle aspiration or local/ systemic treatment). The discordance rate for [18F]FDOPA reading was 20.8% (95%CI: 7.1-42.2, 5/24 patients). CONCLUSION: In this multicenter prospective study, [18F]FDOPA is more effective than CI for detecting metastatic lymph nodes and would change management in 58% of cases. The [18F]FDOPA reading remains challenging and requires a learning curve in case of MTC.
引用
- Terroir M, Lusque A, Hindié E, et al. Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery. Eur J Nucl Med Mol Imaging. 2026. PMID: 42337037. doi:10.1007/s00259-026-07992-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。